FIELD: medicine.
SUBSTANCE: method for the topical treatment of eosinophilic esophagitis (hereinafter – EoE) in a patient who needs it with an orally disintegrating pharmaceutical composition containing oral corticosteroid includes the injection of the pharmaceutical composition, when the patient is in a lying position or within 5 minutes before the patient takes the lying position, while the therapeutically effective amount of oral corticosteroid contacts with esophagus, thereby performing the topical treatment of EoE.
EFFECT: invention provides for the effect of increasing clearance of eosinophils in the distal esophagus, while maintaining high clearance of eosinophils in the proximal esophagus.
28 cl, 10 dwg, 21 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS FOR TREATMENT OF ACTIVE EOSINOPHILIC ESOPHAGITIS | 2018 |
|
RU2776651C2 |
METHODS FOR TREATING EOSINOPHILIC ESOPHAGITIS BY ADMINISTERING AN IL-4R INHIBITOR | 2014 |
|
RU2679141C2 |
APPLIANCE OF SOLIFENACIN AND SALIVA FLOW STIMULATORS FOR THE TREATMENT OF OVERACTIVE BLADDER | 2012 |
|
RU2671575C2 |
TREATMENT OF IgE-MEDIATED ALLERGIC DISEASES | 2018 |
|
RU2800765C2 |
CORTICOSTEROID COMPOSITIONS | 2008 |
|
RU2491074C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING DGLA, AND USE THEREOF | 2015 |
|
RU2714323C2 |
METHODS FOR REDUCING BINGE OR COMPULSIVE EATING | 2011 |
|
RU2620913C2 |
FXR AGONISTS APPLICATION METHODS | 2017 |
|
RU2743075C2 |
METHOD FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES WITH TRADIPITANT | 2018 |
|
RU2797248C2 |
METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2713406C2 |
Authors
Dates
2022-03-15—Published
2017-08-18—Filed